Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

2.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

3.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

4.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

5.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot